SG10201703245SA - Fragments of the pa subunit of rna dependent rna polymerase from pandemic influenza virus a 2009 h1n1, and their use - Google Patents
Fragments of the pa subunit of rna dependent rna polymerase from pandemic influenza virus a 2009 h1n1, and their useInfo
- Publication number
- SG10201703245SA SG10201703245SA SG10201703245SA SG10201703245SA SG10201703245SA SG 10201703245S A SG10201703245S A SG 10201703245SA SG 10201703245S A SG10201703245S A SG 10201703245SA SG 10201703245S A SG10201703245S A SG 10201703245SA SG 10201703245S A SG10201703245S A SG 10201703245SA
- Authority
- SG
- Singapore
- Prior art keywords
- subunit
- fragments
- influenza virus
- pandemic influenza
- rna polymerase
- Prior art date
Links
- 241001500351 Influenzavirus A Species 0.000 title 1
- 108060004795 Methyltransferase Proteins 0.000 title 1
- 239000012634 fragment Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/11—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
- C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
- G16B15/30—Drug targeting using structural data; Docking or binding prediction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Medical Informatics (AREA)
- Theoretical Computer Science (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34033510P | 2010-03-16 | 2010-03-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201703245SA true SG10201703245SA (en) | 2017-05-30 |
Family
ID=43983275
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201703245SA SG10201703245SA (en) | 2010-03-16 | 2011-03-15 | Fragments of the pa subunit of rna dependent rna polymerase from pandemic influenza virus a 2009 h1n1, and their use |
SG10201601365RA SG10201601365RA (en) | 2010-03-16 | 2011-03-15 | Fragments of the pa subunit of rna dependent rna polymerase from pandemic influenza virus a 2009 h1n1, and their use |
SG2012061081A SG183375A1 (en) | 2010-03-16 | 2011-03-15 | Fragments of the pa subunit of rna dependent rna polymerase from pandemic influenza virus a 2009 h1n1, and their use |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201601365RA SG10201601365RA (en) | 2010-03-16 | 2011-03-15 | Fragments of the pa subunit of rna dependent rna polymerase from pandemic influenza virus a 2009 h1n1, and their use |
SG2012061081A SG183375A1 (en) | 2010-03-16 | 2011-03-15 | Fragments of the pa subunit of rna dependent rna polymerase from pandemic influenza virus a 2009 h1n1, and their use |
Country Status (12)
Country | Link |
---|---|
US (3) | US9181307B2 (ja) |
EP (1) | EP2547696B1 (ja) |
JP (2) | JP2013521786A (ja) |
KR (1) | KR20130075726A (ja) |
CN (2) | CN102803288B (ja) |
AU (1) | AU2011229469B2 (ja) |
BR (1) | BR112012023166A2 (ja) |
CA (1) | CA2790183A1 (ja) |
IL (1) | IL260192A (ja) |
MX (1) | MX352906B (ja) |
SG (3) | SG10201703245SA (ja) |
WO (1) | WO2011113579A2 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG10201703245SA (en) * | 2010-03-16 | 2017-05-30 | European Molecular Biology Lab Embl | Fragments of the pa subunit of rna dependent rna polymerase from pandemic influenza virus a 2009 h1n1, and their use |
US8859290B2 (en) * | 2011-07-22 | 2014-10-14 | Rutgers, The State University Of New Jersey | Inhibitors of influenza endonuclease activity and tools for their discovery |
JP6918305B2 (ja) * | 2017-03-10 | 2021-08-11 | 地方独立行政法人神奈川県立産業技術総合研究所 | インフルエンザウイルスの増殖を阻害するモノクローナル抗体 |
CN112837764B (zh) * | 2021-01-21 | 2023-07-07 | 北京晶泰科技有限公司 | 分子杂交方法及平台 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2340475T3 (es) * | 2002-05-01 | 2010-06-04 | Vertex Pharmaceuticals Incorporated | Estructura cristalizada de proteina aurora-2 y sus bolsillos de union. |
EP2197901B1 (en) * | 2007-10-09 | 2013-12-11 | European Molecular Biology Laboratory (Embl) | Soluble fragments of influenza virus pb2 protein capable of binding rna-cap |
CN101514335B (zh) * | 2008-02-22 | 2013-04-17 | 中国科学院生物物理研究所 | 流感病毒聚合酶亚基pa的表达纯化及pa氨基端及pa羧基端与pb1氨基端多肽复合体的晶体结构 |
SG10201703245SA (en) | 2010-03-16 | 2017-05-30 | European Molecular Biology Lab Embl | Fragments of the pa subunit of rna dependent rna polymerase from pandemic influenza virus a 2009 h1n1, and their use |
-
2011
- 2011-03-15 SG SG10201703245SA patent/SG10201703245SA/en unknown
- 2011-03-15 KR KR1020127026664A patent/KR20130075726A/ko active Search and Examination
- 2011-03-15 CA CA2790183A patent/CA2790183A1/en active Pending
- 2011-03-15 AU AU2011229469A patent/AU2011229469B2/en not_active Ceased
- 2011-03-15 BR BR112012023166-9A patent/BR112012023166A2/pt not_active IP Right Cessation
- 2011-03-15 SG SG10201601365RA patent/SG10201601365RA/en unknown
- 2011-03-15 EP EP11709643.8A patent/EP2547696B1/en not_active Not-in-force
- 2011-03-15 SG SG2012061081A patent/SG183375A1/en unknown
- 2011-03-15 JP JP2012557443A patent/JP2013521786A/ja not_active Withdrawn
- 2011-03-15 US US13/635,064 patent/US9181307B2/en not_active Expired - Fee Related
- 2011-03-15 CN CN201180014380.9A patent/CN102803288B/zh not_active Expired - Fee Related
- 2011-03-15 MX MX2012010652A patent/MX352906B/es active IP Right Grant
- 2011-03-15 CN CN201510595018.5A patent/CN105273066A/zh active Pending
- 2011-03-15 WO PCT/EP2011/001274 patent/WO2011113579A2/en active Application Filing
-
2015
- 2015-06-26 US US14/751,634 patent/US9783794B2/en not_active Expired - Fee Related
-
2016
- 2016-03-17 JP JP2016053802A patent/JP2016189772A/ja active Pending
-
2017
- 2017-08-08 US US15/672,091 patent/US20180044649A1/en not_active Abandoned
-
2018
- 2018-06-21 IL IL260192A patent/IL260192A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2011113579A3 (en) | 2012-08-02 |
CN105273066A (zh) | 2016-01-27 |
US20180044649A1 (en) | 2018-02-15 |
AU2011229469A1 (en) | 2012-09-06 |
EP2547696B1 (en) | 2018-05-23 |
US9783794B2 (en) | 2017-10-10 |
KR20130075726A (ko) | 2013-07-05 |
SG183375A1 (en) | 2012-09-27 |
CN102803288B (zh) | 2015-09-23 |
WO2011113579A2 (en) | 2011-09-22 |
AU2011229469B2 (en) | 2015-01-22 |
CA2790183A1 (en) | 2011-09-22 |
US20130023565A1 (en) | 2013-01-24 |
BR112012023166A2 (pt) | 2020-08-25 |
JP2013521786A (ja) | 2013-06-13 |
IL260192A (en) | 2018-07-31 |
US9181307B2 (en) | 2015-11-10 |
US20160053241A1 (en) | 2016-02-25 |
MX352906B (es) | 2017-12-13 |
EP2547696A2 (en) | 2013-01-23 |
JP2016189772A (ja) | 2016-11-10 |
SG10201601365RA (en) | 2016-03-30 |
CN102803288A (zh) | 2012-11-28 |
MX2012010652A (es) | 2013-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL284578A (en) | Double-stranded RNA suppressors of the hepatitis B virus, preparations containing them and their uses | |
IL262123A (en) | Influenza virus vaccines and their uses | |
IL244597B (en) | Replication suppressors of influenza viruses, preparations containing them and their uses | |
EP2552479A4 (en) | INFLUENZA VIRUS VACCINES AND USES THEREOF | |
HK1199211A1 (en) | Influenza virus vaccines and uses thereof | |
HK1149176A1 (en) | Vaccines against multiple subtypes of influenza virus | |
AP2012006067A0 (en) | Inhibitors of influenza viruses replication. | |
HRP20130634T1 (hr) | Cijepljenje sa višestrukim kladovima virusa h5 influence a | |
EP2318043A4 (en) | INFLUENZA HEMAGGLUTININE AND NEURAMINIDASE VARIANTS | |
EP2223934A4 (en) | METHOD FOR INHIBITING A GRIPPEVIRUS INFECTION, AND MEDICAMENT THEREFOR | |
EP2118323A4 (en) | DETECTION OF INFLUENZA VIRUS | |
HK1203524A1 (en) | Computationally optimized broadly reactive antigens for h3n2, h2n2, and b influenza viruses h3n2h2n2 b | |
EP2442826A4 (en) | INFLUENZA VACCINE, COMPOSITION, AND METHODS OF USE | |
EP2277891A4 (en) | CRYSTAL STRUCTURE OF THE POLYMERASE PAC-PB1N COMPLEX OF THE FLUID VIRUS AND USES THEREOF | |
ZA200809056B (en) | Influenza virus vaccine | |
AP2013006835A0 (en) | Novel vaccines against the A/H1N1 pandemic flu virus | |
GB201203547D0 (en) | Multiplex real-time PCR detection of influenza viruses 2009 H1N1, influenza A and influenza B | |
EP2640405A4 (en) | TREATMENT AND / OR CHARACTERIZATION OF INFLUENZA; POLYPEPTIDES HA ADAPTED TO MAN | |
SG10201601365RA (en) | Fragments of the pa subunit of rna dependent rna polymerase from pandemic influenza virus a 2009 h1n1, and their use | |
SG2014010185A (en) | Influenza hemagglutinin and neuraminidase variants | |
EP2314679A4 (en) | CONSTRUCTION OF AN EXPRESSION SYSTEM FOR RNA FROM INFLUENZAVIRUS RNA POLYMERASE, CRYSTALLIZATION OF RNA POLYMERASE AND SCREENING METHOD FOR ANTIGRAPHIC AGENT | |
HK1177692A1 (zh) | 新的流感病毒 | |
EP2340844A4 (en) | AVIAN INFLUENZA ANTI-VIRUS AGENT AND PRODUCT COMPRISING AVIAN INFLUENZA ANTI-VIRUS AGENT | |
SG10201403219XA (en) | Influenza Vaccine, Composition, And Methods Of Use |